Circulating periostin levels do not differ between postmenopausal women with normal and low bone mass and are not affected by zoledronic acid treatment

Hormone and Metabolic Research

Volumn 46, Issue 2, 2014, Pages 145-149

  Anastasilakis, A D ^a   Polyzos, S A ^b   Makras, P ^c   Savvides, M ^a   Sakellariou, G T ^a   Gkiomisi, A ^a   Papatheodorou, A ^c   Terpos, E ^d  

^a 424 General Army Hospital   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c IASO GENERAL HOSPITAL   (Greece)

^d UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

bone metabolism; osteoporosis; periostin; zoledronic acid

Indexed keywords

AGED; ALKALINE PHOSPHATASE; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; CELL ADHESION MOLECULES; COLLAGEN TYPE I; DIPHOSPHONATES; FEMALE; HUMANS; IMIDAZOLES; MIDDLE AGED; PARATHYROID HORMONE; PEPTIDES; POSTMENOPAUSE; VITAMIN D;

EID: 84894226429     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0033-1351250     Document Type: Article

References (18)

1. Coutu D. L., Wu J. H., Monette A., Rivard G. E., Blostein M. D., Galipeau J. Periostin, a member of a novel family of vitamin K-dependent proteins, is expressed by mesenchymal stromal cells. J Biol Chem: 2008; 283 17991 18001
2. Horiuchi K., Amizuka N., Takeshita S., Takamatsu H., Katsuura M., Ozawa H., Toyama Y., Bonewald L. F., Kudo A. Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta. J Bone Miner Res: 1999; 14 1239 1249 (Pubitemid 29314070)
3. Merle B., Garnero P. The multiple facets of periostin in bone metabolism. Osteoporos Int: 2012; 23 1199 1212
4. Litvin J., Selim A. H., Montgomery M. O., Lehmann K., Rico M. C., Devlin H., Bednarik D. P., Safadi F. F. Expression and function of periostin-isoforms in bone. J Cell Biochem: 2004; 92 1044 1061 (Pubitemid 44264252)
5. Bonnet N., Conway S. J., Ferrari S. L. Regulation of beta catenin signaling and parathyroid hormone anabolic effects in bone by the matricellular protein periostin. Proc Natl Acad Sci USA: 2012; 109 15048 15053
6. Zhu S., Barbe M. F., Liu C., Hadjiargyrou M., Popoff S. N., Rani S., Safadi F. F., Litvin J. Periostin-like-factor in osteogenesis. J Cell Physiol: 2009; 218 584 592
7. Norris R. A., Damon B., Mironov V., Kasyanov V., Ramamurthi A., Moreno-Rodriguez R., Trusk T., Potts J. D., Goodwin R. L., Davis J., Hoffman S., Wen X., Sugi Y., Kern C. B., Mjaatvedt C. H., Turner D. K., Oka T., Conway S. J., Molkentin J. D., Forgacs G., Markwald R. R. Periostin regulates collagen fibrillogenesis and the biomechanical properties of connective tissues. J Cell Biochem: 2007; 101 695 711 (Pubitemid 46698854)
8. Xiao S. M., Gao Y., Cheung C. L., Bow C. H., Lau K. S., Sham P. C., Tan K. C., Kung A. W. Association of CDX1 binding site of periostin gene with bone mineral density and vertebral fracture risk. Osteoporos Int: 2012; 23 1877 1887
9. Reid I. R., Brown J. P., Burckhardt P., Horowitz Z., Richardson P., Trechsel U., Widmer A., Devogelaer J. P., Kaufman J. M., Jaeger P., Body J. J., Brandi M. L., Broell J., Di Micco R., Genazzani A. R., Felsenberg D., Happ J., Hooper M. J., Ittner J., Leb G., Mallmin H., Murray T., Ortolani S., Rubinacci A., Saaf M., Samsioe G., Verbruggen L., Meunier P. J. Intravenous zoledronic acid in postmenopausal women with low bone mineral density. N Engl J Med: 2002; 346 653 661 (Pubitemid 34815869)
10. Koch F. P., Merkel C., Al-Nawas B., Smeets R., Ziebart T., Walter C., Wagner W. Zoledronate, ibandronate and clodronate enhance osteoblast differentiation in a dose dependent manner - a quantitative in vitro gene expression analysis of Dlx5, Runx2, OCN, MSX1 and MSX2. J Craniomaxillofac Surg: 2011; 39 562 569
11. Koch F. P., Yekta S. S., Merkel C., Ziebart T., Smeets R. The impact of bisphosphonates on the osteoblast proliferation and Collagen gene expression in vitro. Head Face Med: 2010; 6 12
12. Im G., Qureshi S. A., Kenney J., Rubash H. E., Shanbhag A. S. Osteoblast proliferation and maturation by bisphosphonates. Biomaterials: 2004; 25 4105 4115 (Pubitemid 38388576)
13. Fromigué O., Body J. J. Bisphosphonates influence the proliferation and the maturation of normal human osteoblasts. J Endocrinol Invest: 2002; 25 539 546 (Pubitemid 34661843)
14. Klein B. Y., Ben-Bassat H., Breuer E., Solomon V., Golomb G. Structurally different bisphosphonates exert opposing effects on alkaline phosphatase and mineralization in marrow osteoprogenitors. J Cell Biochem: 1998; 68 186 194 (Pubitemid 28028076)
15. Stock M., Schafer H., Fliegauf M., Otto F. Identification of novel genes of the bone-specific transcription factor Runx2. J Bone Miner Res: 2004; 19 959 972 (Pubitemid 41103453)
16. Bonnet N., Standley K. N., Bianchi E. N., Stadelmann V., Foti M., Conway S. J., Ferrari S. L. The matricellular protein periostin is required for sost inhibition and the anabolic response to mechanical loading and physical activity. J Biol Chem: 2009; 284 35939 35950
17. Contié S., Voorzanger-Rousselot N., Litvin J., Bonnet N., Ferrari S., Clézardin P., Garnero P. Development of a new ELISA for serum periostin: evaluation of growth-related changes and bisphosphonate treatment in mice. Calcif Tissue Int: 2010; 87 341 350
18. Fortunati D., Reppe S., Fjeldheim A. K., Nielsen M., Gautvik V. T., Gautvik K. M. Periostin is a collagen associated bone matrix protein regulated by parathyroid hormone. Matrix Biol: 2010; 29 594 601